News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Experts Update Antithrombotic Advice in AF Patients Undergoing PCI Todd Neale February 09, 2021
News Daily News Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups Todd Neale February 01, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19 Michael O'Riordan June 08, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights Shelley Wood December 02, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016